Short-term risk of recurrence in patients (pts) with HR+/HER2− early breast cancer (EBC) treated with endocrine therapy (ET) in randomized clinical trials (RCTs): A meta-analysis.

Category Systematic review
JournalJ. Clin. Oncol.
Year 2024
This article has no abstract
Epistemonikos ID: e0df93b4527c59d3cc1dbf37adf92de8488c34d9
First added on: Dec 17, 2025